Quincy Bioscience doesn’t admit to “any liability or wrongdoing of any kind associated with the claims alleged” in settlement to complaint in federal court in Florida, but agrees to pay plaintiffs refunds of 30% of the MSRP for its supplements, up to $70 per individual claimant.

Factor Nutrition will remove “#1 Brain Health Supplement” claim from Focus Factor supplement and won’t replace it with “America’s #1 Clinically Studied and Patented Brain Health Formula” after the National Advertising Division determines it lacks supporting sales and clinical data.

Prevagen containers since 2013 have been labeled with an "improve memory," but the package a plaintiff purchased in 2014 apparently didn't bear the claim, according to a court ruling. A receipt for the purchase indicated the product was identified with “Brain Cell Protection” on the label.

District court erred in dismissing FTC complaint that Prevagen marketer Quincy Biosciences used deceptive representations in ads, Second Circuit says in long-awaited order. FTC and New York attorney general, along with advocacy group TINA, criticize Quincy's post hoc data analyses finding "false positives."